Glucagonoma and the glucagonoma syndrome - cumulative experience with an elusive endocrine tumour

Abstract

Our data indicate that somatostatin analogues and an aggressive surgical approach offer symptom relief and tumour control. Among other available treatment modalities, PRRT seems to hold the most promise.